22717

544122

ENTERO

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

ENTERO HEALTHCARE SOLU L Share Price Today

ENTERO HEALTHCARE SOLU L is currently trading at ₹1180.4, up by ₹17.09 from the previous close. The stock touched an intraday high of ₹1197.90 and a low of ₹1145.20 during the latest trading session. Over the past one year, ENTERO HEALTHCARE SOLU L has delivered a return of 2.19%, while the stock has declined 13.79% in the last one month.

ENTERO HEALTHCARE SOLU L performance

Today’s low Today’s high
₹ 1145.20 ₹ 1197.90
₹ 1180.40
52 week low 52 week high
₹ 944.00 ₹ 1390.00
₹ 1180.40
Open Price ₹ 1172.60
Prev. Close ₹ 1163.30
Volume (Shares) 162164.00
Total traded value ₹ 1914.18
Upper Circuit ₹ 1395.90
Lower Circuit ₹ 930.70
info

Investment Returns

Over 1 Month -13.79% Over 3 Months -5.11% Over 6 Months 20.83% Over 1 Year 2.19%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

ENTERO HEALTHCARE SOLU L fundamentals


  • Market cap (Cr) 5,137.30
  • P/E Ratio (TTM) 188.25
  • Beta 0.19
  • Book Value / share 386.71
  • Return on equity 3.15%
  • EPS (TTM) 6.90
  • Dividend yield 0.00%
  • Net profit/quarter (Cr) 13.42
info icon alternate text
  • Market cap (Cr) 5,126.80
  • P/E Ratio (TTM) 188.25
  • Beta 0.17
  • Book Value / share 386.71
  • Return on equity 3.15%
  • EPS (TTM) 6.90
  • Dividend yield 0.00%
  • Net profit/quarter (Cr) 13.42
info icon alternate text

ENTERO HEALTHCARE SOLU L Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars MAR 2026 (Values in Cr)
Revenue 78.93
Operating Expense 106.85
Net Profit 13.42
Net Profit Margin (%) 17.00
Earnings Per Share (EPS) 3.08
EBITDA 17.41
Effective Tax Rate (%) -11.46
Particulars DEC 2025 (Values in Cr)
Revenue 106.74
Operating Expense 124.12
Net Profit 0.81
Net Profit Margin (%) 0.75
Earnings Per Share (EPS) 0.18
EBITDA 4.87
Effective Tax Rate (%) 41.60
Particulars SEP 2025 (Values in Cr)
Revenue 83.22
Operating Expense 99.83
Net Profit 5.70
Net Profit Margin (%) 6.84
Earnings Per Share (EPS) 1.31
EBITDA 11.64
Effective Tax Rate (%) 25.09
Particulars JUN 2025 (Values in Cr)
Revenue 79.35
Operating Expense 96.47
Net Profit 6.96
Net Profit Margin (%) 8.77
Earnings Per Share (EPS) 1.60
EBITDA 12.57
Effective Tax Rate (%) 24.12
Particulars MAR 2025 (Values in Cr)
Revenue 72.30
Operating Expense 86.75
Net Profit -27.81
Net Profit Margin (%) -38.46
Earnings Per Share (EPS) -6.39
EBITDA -33.14
Effective Tax Rate (%) 22.01
Particulars MAR 2026 (Values in Cr)
Revenue 348.24
Operating Expense 427.28
Net Profit 26.88
Net Profit Margin (%) 7.71
Earnings Per Share (EPS) 6.18
EBITDA 46.52
Effective Tax Rate (%) 10.96
Particulars MAR 2025 (Values in Cr)
Revenue 408.67
Operating Expense 449.18
Net Profit 19.18
Net Profit Margin (%) 4.69
Earnings Per Share (EPS) 4.41
EBITDA 36.95
Effective Tax Rate (%) 28.37
Particulars MAR 2024 (Values in Cr)
Revenue 318.16
Operating Expense 383.71
Net Profit 38.44
Net Profit Margin (%) 12.08
Earnings Per Share (EPS) 10.63
EBITDA 55.44
Effective Tax Rate (%) -57.77
Particulars MAR 2023 (Values in Cr)
Revenue 177.69
Operating Expense 242.71
Net Profit -12.46
Net Profit Margin (%) -7.01
Earnings Per Share (EPS) -30.28
EBITDA 8.64
Effective Tax Rate (%) 0.00
Particulars MAR 2022 (Values in Cr)
Revenue 137.29
Operating Expense 205.01
Net Profit -40.85
Net Profit Margin (%) -29.75
Earnings Per Share (EPS) -0.72
EBITDA -26.85
Effective Tax Rate (%) 0.00
Particulars MAR 2025 (Values in Cr)
Book Value / Share 395.31
ROE % 6.33
ROCE % 8.70
Total Debt to Total Equity 0.22
EBITDA Margin 4.14
Particulars MAR 2024 (Values in Cr)
Book Value / Share 376.21
ROE % 4.96
ROCE % 6.63
Total Debt to Total Equity 0.35
EBITDA Margin 3.22
Particulars MAR 2023 (Values in Cr)
Book Value / Share -166.80
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.69
EBITDA Margin 2.11
Particulars MAR 2022 (Values in Cr)
Book Value / Share -150.52
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.53
EBITDA Margin 1.15
Particulars MAR 2021 (Values in Cr)
Book Value / Share -3168.27
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.40
EBITDA Margin 1.44
Particulars MAR 2025 (Values in Cr)
Book Value / Share 378.35
ROE % 3.15
ROCE % 4.43
Total Debt to Total Equity 0.01
EBITDA Margin 20.50
Particulars MAR 2024 (Values in Cr)
Book Value / Share 373.53
ROE % 4.83
ROCE % 3.91
Total Debt to Total Equity 0.06
EBITDA Margin 17.42
Particulars MAR 2023 (Values in Cr)
Book Value / Share -194.27
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.15
EBITDA Margin 4.87
Particulars MAR 2022 (Values in Cr)
Book Value / Share -176.06
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.08
EBITDA Margin -19.55
Particulars MAR 2021 (Values in Cr)
Book Value / Share -3067.50
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.05
EBITDA Margin -8.15
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 260.42
Total Assets 2702.51
Total Liabilities 2702.51
Total Equity 1770.35
Share Outstanding 4
Price to Book Ratio 3.00
Return on Assets (%) 3.50
Return on Capital (%) 4.58
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 893.18
Total Assets 2344.97
Total Liabilities 2344.97
Total Equity 1641.38
Share Outstanding 4
Price to Book Ratio 2.64
Return on Assets (%) 1.66
Return on Capital (%) 2.04
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 106.84
Total Assets 1308.72
Total Liabilities 1308.72
Total Equity 597.66
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) -0.88
Return on Capital (%) -1.19
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 105.39
Total Assets 1125.98
Total Liabilities 1125.98
Total Equity 563.21
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) -2.65
Return on Capital (%) -3.53
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 82.82
Total Assets 835.96
Total Liabilities 835.96
Total Equity 487.06
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) -1.85
Return on Capital (%) -2.47
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 170.06
Total Assets 1803.53
Total Liabilities 1803.53
Total Equity 1650.38
Share Outstanding 4
Price to Book Ratio 3.00
Return on Assets (%) 1.06
Return on Capital (%) 1.16
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 792.35
Total Assets 1768.58
Total Liabilities 1768.58
Total Equity 1626.41
Share Outstanding 4
Price to Book Ratio 2.64
Return on Assets (%) 2.17
Return on Capital (%) 2.36
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 77.18
Total Assets 763.56
Total Liabilities 763.56
Total Equity 583.73
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) -1.63
Return on Capital (%) -1.84
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 88.24
Total Assets 654.08
Total Liabilities 654.08
Total Equity 551.20
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) -6.24
Return on Capital (%) -7.03
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 66.65
Total Assets 532.70
Total Liabilities 532.70
Total Equity 486.43
Share Outstanding 0
Price to Book Ratio 0.00
Return on Assets (%) -3.40
Return on Capital (%) -3.73
Particulars MAR 2025 (Values in Cr)
Net Income 138.73
Cash from Operations -38.72
Cash from Investing 219.80
Cash from Financing -73.66
Net change in Cash 69.27
Free Cash Flow -27.41
Particulars MAR 2024 (Values in Cr)
Net Income 35.55
Cash from Operations -23.55
Cash from Investing -705.12
Cash from Financing 862.94
Net change in Cash 121.20
Free Cash Flow -18.13
Particulars MAR 2023 (Values in Cr)
Net Income -3.68
Cash from Operations -32.88
Cash from Investing -48.59
Cash from Financing 72.76
Net change in Cash -21.14
Free Cash Flow -27.36
Particulars MAR 2022 (Values in Cr)
Net Income -19.81
Cash from Operations -24.36
Cash from Investing -161.73
Cash from Financing 211.19
Net change in Cash 14.19
Free Cash Flow -14.49
Particulars MAR 2021 (Values in Cr)
Net Income -10.83
Cash from Operations -64.10
Cash from Investing -30.86
Cash from Financing 88.71
Net change in Cash -10.83
Free Cash Flow -54.57
Particulars MAR 2025 (Values in Cr)
Net Income 26.78
Cash from Operations -92.36
Cash from Investing 207.74
Cash from Financing -40.88
Net change in Cash 57.84
Free Cash Flow -90.38
Particulars MAR 2024 (Values in Cr)
Net Income 24.36
Cash from Operations -73.85
Cash from Investing -762.69
Cash from Financing 925.56
Net change in Cash 87.22
Free Cash Flow -72.81
Particulars MAR 2023 (Values in Cr)
Net Income -12.45
Cash from Operations -54.37
Cash from Investing -58.29
Cash from Financing 91.11
Net change in Cash -24.08
Free Cash Flow -53.85
Particulars MAR 2022 (Values in Cr)
Net Income -40.84
Cash from Operations -43.73
Cash from Investing -68.79
Cash from Financing 127.47
Net change in Cash 13.98
Free Cash Flow -41.15
Particulars MAR 2021 (Values in Cr)
Net Income -18.15
Cash from Operations -68.64
Cash from Investing -7.20
Cash from Financing 75.49
Net change in Cash 0.09
Free Cash Flow -62.09
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
APOLLO HOSPITALS ENTER. L 8573.50 63.02 13.01 123273.78 6680.00 8624.20
FORTIS MALAR HOSPITALS LIMITED 52.15 23.60 2.84 97.74 40.75 76.00
SHREE PACETRONIX LTD. 130.30 15.55 2.74 48.86 66.10 283.15
TRANSGENE BIOTEK LTD. 3.03 0.00 2.73 22.96 1.83 5.26
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
APOLLO HOSPITALS ENTER. L 8573.50 82.11 12.37 123273.78 6680.00 8624.20
[-] 0.0 0.0 0.0 0.0 0.0 0.0
CHENNAI MEENAKSHI MULTISPECIAL 41.86 0.00 -10.18 31.27 30.30 57.48
KOVAI MEDICAL CENTER & HO 6074.95 27.19 5.03 6646.00 5010.00 6725.00

ENTERO HEALTHCARE SOLU L shareholding pattern

Holding
26.93%
52.41%
4.02%
16.62%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

ENTERO HEALTHCARE SOLU L Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
1180.40 1.46 redarrow
red-green-graph indicator
1 Bearish
15 Bullish
  • 5 Days 1119.40
  • 26 Days 1148.30
  • 10 Days 1120.30
  • 50 Days 1163.80
  • 12 Days 1123.50
  • 100 Days 1160.30
  • 20 Days 1138.80
  • 200 Days 1162.00
1150.43 PIVOT
First Support 1102.87 First Resistance 1210.87 Second Support 1042.43 Second Resistance 1258.43 Third Support 994.87 Third Resistance 1318.87
RSI 52.37 ADX 6.78 MACD -24.71 Williams % R -31.04 Commodity Channel Index (CCI) 48.63
Date 2026-06-24 Week 58054.00 Same Day 109156.00 Month 78926.00
1 Year 0.20 3 Year 0.41
Over 1 Month
-13.79% down
Over 1 Year
2.19% down
Over 3 Months
-5.11% down
Over 3 Years
0.39% down
Over 6 Months
20.83% down
Over 5 Years
0.00% down

ENTERO HEALTHCARE SOLU L Corporate Actions

Top Gainers

Top Losers

stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Entero Healthcare Solutions Ltd?

Answer Field

Entero Healthcare Solutions Ltd share price is for NSE ₹ 1,180.40 & for BSE ₹ 1,178.00 as on Jun 25 2026 03:30 PM.

What is the Market Cap of Entero Healthcare Solutions Ltd Share?

Answer Field

The market cap of Entero Healthcare Solutions Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on Jun 25 2026 03:30 PM.

What is the 52 Week High and Low of Entero Healthcare Solutions Ltd?

Answer Field

The 52 Week High and Low of Entero Healthcare Solutions Ltd for NSE is ₹ 1,390.00 and ₹ 944.00 and for BSE is ₹ 1,390.00 and ₹ 944.00.

What is 1 year return for Entero Healthcare Solutions Ltd?

Answer Field

The 1 year returns on the stock has been 2.19%.

What is the P/E Ratio of Entero Healthcare Solutions Ltd Share?

Answer Field

As on Jun 25 2026 03:30 PM the price-to-earnings (PE) ratio for Entero Healthcare Solutions Ltd share is 188.25.

What is the PB ratio of Entero Healthcare Solutions Ltd Share?

Answer Field

As on Jun 25 2026 03:30 PM, the price-to-book (PB) ratio for Entero Healthcare Solutions Ltd share is 386.71.

How to Buy Entero Healthcare Solutions Ltd Share?

Answer Field

You can trade in Entero Healthcare Solutions Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Entero Healthcare Solutions Ltd Share on Bajaj Broking App?

Answer Field

To buy Entero Healthcare Solutions Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Entero Healthcare Solutions Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image
Get Free Demat Account*
+91
close-img
Authorise with OTP
Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|